Zydus Cadila gets USFDA’s final nod for fungal treatment drug

Drug firm ZydusCadila has received final approval from the US health regulator to market Voriconazole tablets, used to treat fungal infections, in the American market.The ZydusCadila has received final approval from the US Food and Drug Administration (USFDA) to market Voriconazole tablets in strengths of 50 and 200 mg, CadilaHealhtcare said in a BSE filing.

The drug will be produced at the groups formulations manufacturing facility at Baddi (Himachal Pradesh).

Citing IMS data, the company said the estimated sales for Voriconazole tablets is USD 92.8 million as on March 2016.

Related Posts

Lupin launches Ipratropium Bromide nasal spray in US

Pharma major Lupin Ltd on Friday said it has launched Ipratropium Bromide nasal spray, used in treatment of runny nose, in the US market. The Ipratropium Bromide nasal solution (nasal…

12 dead, 13 workers rescued as reactor blast rips through pharma unit near Hyderabad

Bodies of 12 workers were brought out and 13 others were rescued from under the debris after a blast in a reactor unit at Sigachi Industries Pvt. Ltd. in the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump pressures 17 pharma CEOs to cut US drug prices

Trump pressures 17 pharma CEOs to cut US drug prices

Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

Karnataka issues order to merge Ayush drug dept with State FDA

Karnataka issues order to merge Ayush drug dept with State FDA

Orchid Pharma buyback rights to novel antibiotic; stock up 5%

Orchid Pharma buyback rights to novel antibiotic; stock up 5%